Optos focuses on retinal diagnostics with OPKO Instrumentation purchase
This article was originally published in Clinica
Executive Summary
Retinal imaging specialist Optos has broadened its footprint in the ophthalmic diagnostics market by agreeing to buy OPKO Health’s instrumentation division for $17.5m. Optos will also make royalty payments to OPKO, depending on future revenues, at a rate of 2.5% or 5%. Royalties payable will not exceed $22.5m in aggregate, suggesting accumulated sales of at least $450m, according to Nomura Code analyst Gary Waanders.